» Articles » PMID: 27539729

SGO1 is Involved in the DNA Damage Response in MYCN-amplified Neuroblastoma Cells

Overview
Journal Sci Rep
Specialty Science
Date 2016 Aug 20
PMID 27539729
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Shugoshin 1 (SGO1) is required for accurate chromosome segregation during mitosis and meiosis; however, its other functions, especially at interphase, are not clearly understood. Here, we found that downregulation of SGO1 caused a synergistic phenotype in cells overexpressing MYCN. Downregulation of SGO1 impaired proliferation and induced DNA damage followed by a senescence-like phenotype only in MYCN-overexpressing neuroblastoma cells. In these cells, SGO1 knockdown induced DNA damage, even during interphase, and this effect was independent of cohesin. Furthermore, MYCN-promoted SGO1 transcription and SGO1 expression tended to be higher in MYCN- or MYC-overexpressing cancers. Together, these findings indicate that SGO1 plays a role in the DNA damage response in interphase. Therefore, we propose that SGO1 represents a potential molecular target for treatment of MYCN-amplified neuroblastoma.

Citing Articles

Shugoshin 1 expression in various cancers: a potential target for therapy.

Ankathatti Narayanaswamy I, Kattepur A, Raju K, Perumal V, Ramalingam R, Raavi V Clin Transl Oncol. 2024; .

PMID: 39476301 DOI: 10.1007/s12094-024-03749-1.


Repression of developmental transcription factor networks triggers aging-associated gene expression in human glial progenitor cells.

Mariani J, Mansky B, Madsen P, Salinas D, Kesmen D, Huynh N Nat Commun. 2024; 15(1):3873.

PMID: 38719882 PMC: 11079006. DOI: 10.1038/s41467-024-48118-2.


Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.

Yang Z, Jiang Y, Wang L, Yu B, Cai H, Fan J BMC Med Genomics. 2024; 17(1):60.

PMID: 38383432 PMC: 10882763. DOI: 10.1186/s12920-024-01825-7.


Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation.

Bogdanov K, Kudryavtseva E, Fomicheva Y, Churkina I, Lomaia E, Girshova L Pathophysiology. 2023; 30(3):296-313.

PMID: 37606386 PMC: 10443239. DOI: 10.3390/pathophysiology30030024.


A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle.

Li H, Dong L, Jin M, Li Q, Wang X, Jia M Molecules. 2023; 28(3).

PMID: 36770809 PMC: 9920120. DOI: 10.3390/molecules28031141.


References
1.
Tanno Y, Kitajima T, Honda T, Ando Y, Ishiguro K, Watanabe Y . Phosphorylation of mammalian Sgo2 by Aurora B recruits PP2A and MCAK to centromeres. Genes Dev. 2010; 24(19):2169-79. PMC: 2947769. DOI: 10.1101/gad.1945310. View

2.
Hoglund A, Stromvall K, Li Y, Forshell L, Nilsson J . Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition. Cell Cycle. 2011; 10(20):3598-607. PMC: 3266184. DOI: 10.4161/cc.10.20.17887. View

3.
Giunta S, Belotserkovskaya R, Jackson S . DNA damage signaling in response to double-strand breaks during mitosis. J Cell Biol. 2010; 190(2):197-207. PMC: 2930281. DOI: 10.1083/jcb.200911156. View

4.
Li Z, Van Calcar S, Qu C, Cavenee W, Zhang M, Ren B . A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 2003; 100(14):8164-9. PMC: 166200. DOI: 10.1073/pnas.1332764100. View

5.
Yang J, Ikezoe T, Nishioka C, Yokoyama A . A novel treatment strategy targeting shugoshin 1 in hematological malignancies. Leuk Res. 2012; 37(1):76-82. DOI: 10.1016/j.leukres.2012.10.002. View